08:00 , Feb 4, 2013 |  BioCentury  |  Emerging Company Profile

Incanthera: Using, not targeting, MMP

Incanthera Ltd. has found a new use for a class of enzymes that are up-regulated in tumors and contribute to cancer progression. Rather than design inhibitors of matrix metalloproteinases , the biotech is instead using...
08:00 , Mar 15, 2004 |  BioCentury  |  Strategy

Fitting in with AstraZeneca

Fitting in with AstraZeneca...